{
  "id": "5a8715a961bb38fb24000006",
  "type": "factoid",
  "question": "Silent Allosteric Modulation of mGluR5 is a form of treatment for what disease?",
  "ideal_answer": "silent allosteric modulation of mGluR5 has promise as a disease-modifying AD intervention with a broad therapeutic window. ",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28683325",
    "http://www.ncbi.nlm.nih.gov/pubmed/25148681"
  ],
  "snippets": [
    {
      "text": "silent allosteric modulation of mGluR5 has promise as a disease-modifying AD intervention with a broad therapeutic window.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28683325",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In brain homogenates with A\u03b2o, the interaction of PrP(C) and mGluR5 is reversed by mGluR5-directed antagonists or antibodies directed against the PrP(C) segment of amino acids 91-153. Silent allosteric modulators of mGluR5 do not alter Glu or basal mGluR5 activity, but they disrupt the A\u03b2o-induced interaction of mGluR5 with PrP(C)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25148681",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The assays described here have the potential to identify and develop new compounds that inhibit the interaction of PrP(C) and mGluR5, which plays a pivotal role in the pathogenesis of Alzheimer disease by transmitting the signal from extracellular A\u03b2o into the cytosol.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25148681",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28683325",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Our data show that mGluR5's role in A\u03b2o-dependent AD phenotypes is separate from its role in glutamate signaling and silent allosteric modulation of mGluR5 has promise as a disease-modifying AD intervention with a broad therapeutic window.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28683325",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Alzheimer's disease"
}